K230501 is an FDA 510(k) clearance for the Spirobank Oxi. This device is classified as a Spirometer, Diagnostic (Class II - Special Controls, product code BZG).
Submitted by Mir Medical International Research USA (New Berlin, US). The FDA issued a Cleared decision on December 15, 2023, 294 days after receiving the submission on February 24, 2023.
This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 868.1840.
| 510(k) Number | K230501 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | February 24, 2023 |
| Decision Date | December 15, 2023 |
| Days to Decision | 294 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
| Product Code | BZG - Spirometer, Diagnostic |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 868.1840 |